1. |
Achanta LB, Rae CD. β-Hydroxybutyrate in the brain: one molecule, multiple mechanisms. Neurochem Res, 2017, 42(1): 35-49.
|
2. |
熊立凡. 临床检验基础. 第 3 版. 北京: 人民卫生出版社, 2003: 134-135.
|
3. |
Walta AM, Keltanen T, Lindroos K, et al. The usefulness of point-of-care (POC) tests in screening elevated glucose and ketone body levels postmortem. Forensic Sci Int, 2016, 266(10): 299-303.
|
4. |
Chong SK, Reineke EL. Point-of-Care Glucose and Ketone Monitoring. Topics in Compan An Med, 2016, 31(4): 18-26.
|
5. |
Ruskin DN, Murphy MI, Slade SL, et al. Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder. PLoS One, 2017, 12(2): e0171643.
|
6. |
White H, Venkatesh B, Jones M, et al. Serial changes in plasma ketone concentrations in patients with acute brain injury. Neuro Res, 2017, 39(1): 1-6.
|
7. |
Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem, 2002, 48(3): 436-472.
|
8. |
卢妙莲, 王建兵, 曹永坚, 等. 两种 POCT 血酮体仪与生化分析仪对 β-羟丁酸检测结果的比对分析. 国际检验医学杂志, 2013, 34(11): 1434-1435.
|
9. |
van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol, 2016, 20(6): 1-12.
|
10. |
Kinsella JM, Barker G, King J, et al. Implementing point of care blood ketone testing in the emergency department. Australas Emerg Nurs J, 2012, 15(2): 63-67.
|
11. |
Wlaz P, Soca1a K, Nieoczym D, et al. Anticonvulsant profile of caprylic acid, a main constituent of the medium-chain triglyceride (MCT) ketogenic diet in mice. Neuropharmacology, 2012, 62(1): 1882-1889.
|